Log in

U.S. Physical Therapy Stock Price, Forecast & Analysis (NYSE:USPH)

$114.27
-0.98 (-0.85 %)
(As of 11/17/2019 10:58 AM ET)
Today's Range
$112.80
Now: $114.27
$115.95
50-Day Range
$113.72
MA: $132.85
$147.27
52-Week Range
$98.69
Now: $114.27
$148.48
Volume274,281 shs
Average Volume104,722 shs
Market Capitalization$1.46 billion
P/E Ratio43.12
Dividend Yield1.04%
Beta1.09
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. Read More…

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.91 million
Cash Flow$3.38 per share
Book Value$18.58 per share

Profitability

Net Income$34.87 million

Miscellaneous

Employees4,600
Market Cap$1.46 billion
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.


U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, November 7th. Stockholders of record on Monday, November 18th will be given a dividend of $0.30 per share on Friday, December 13th. This represents a $1.20 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend is Friday, November 15th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Thursday, November, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.71. The business had revenue of $117.30 million for the quarter, compared to analyst estimates of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. The company's revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.64 earnings per share. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for U.S. Physical Therapy.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY19 earnings guidance on Thursday, November, 7th. The company provided EPS guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.94.

What price target have analysts set for USPH?

2 analysts have issued 12-month price targets for U.S. Physical Therapy's stock. Their forecasts range from $106.61 to $130.00. On average, they expect U.S. Physical Therapy's share price to reach $118.31 in the next year. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
  • 1. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (11/15/2019)
  • 2. Barrington Research analysts commented, "We think this guidance is likely conservative and would not be surprised to see the adjusted EPS guidance increase as early as next quarter. Our current adjusted EPS expectation is $2.92." (5/3/2019)

Has U.S. Physical Therapy been receiving favorable news coverage?

Press coverage about USPH stock has been trending negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for U.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a drop in short interest during the month of October. As of October 31st, there was short interest totalling 1,150,000 shares, a drop of 5.7% from the September 30th total of 1,220,000 shares. Based on an average daily trading volume, of 87,900 shares, the days-to-cover ratio is currently 13.1 days. Currently, 9.2% of the shares of the stock are sold short. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Allergan (AGN), Synergy Pharmaceuticals (SGYP), Cleveland-Cliffs (CLF), CVS Health (CVS), UnitedHealth Group (UNH), Booking (BKNG), Cisco Systems (CSCO), Exponent (EXPO), Illumina (ILMN) and Infinera (INFN).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (2.98%), Copeland Capital Management LLC (1.39%), Russell Investments Group Ltd. (0.95%), Boston Trust Walden Corp (0.92%), Scout Investments Inc. (0.76%) and Carillon Tower Advisers Inc. (0.49%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Hancock Whitney Corp, Alberta Investment Management Corp, Scout Investments Inc., Riverbridge Partners LLC, Systematic Financial Management LP, State of Tennessee Treasury Department and Russell Investments Group Ltd.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, SG Americas Securities LLC, First Trust Advisors LP, Bridge City Capital LLC, Rhumbline Advisers, State of Alaska Department of Revenue, California Public Employees Retirement System and Moloney Securities Asset Management LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $114.27.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.46 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is http://www.usph.com/.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  196 (Vote Outperform)
Underperform Votes:  287 (Vote Underperform)
Total Votes:  483
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel